- Case report
- Open Access
Presumptive thrombotic thrombocytopenic purpura following a hump-nosed viper (Hypnale hypnale) bite: a case report
© Withana et al.; licensee BioMed Central Ltd. 2014
Received: 11 April 2014
Accepted: 10 June 2014
Published: 16 June 2014
Hump-nosed viper bites are frequent in southern India and Sri Lanka. However, the published literature on this snakebite is limited and its venom composition is not well characterized. In this case, we report a patient with thrombotic thrombocytopenic purpura-like syndrome following envenoming which, to the best of our knowledge, has not been reported in the literature before. A 55-year-old woman from southern Sri Lanka presented to the local hospital 12 hours after a hump-nosed viper (Hypnale hypnale) bite. Five days later, she developed a syndrome that was characteristic of thrombotic thrombocytopenic purpura with fever, thrombocytopenia, microangiopathic hemolysis, renal impairment and neurological dysfunction in the form of confusion and coma. Her clinical syndrome and relevant laboratory parameters improved after she was treated with therapeutic plasma exchange. We compared our observations on this patient with the current literature and concluded that thrombotic thrombocytopenic purpura is a theoretically plausible yet unreported manifestation of hump-nosed viper bite up to this moment. This study also provides an important message for clinicians to look out for this complication in hump-nosed viper bites since timely treatment can be lifesaving.
Since TTP has high mortality without prompt recognition and treatment, awareness about this potential complication associated with hump-nosed viper envenoming is lifesaving. Currently there is no licensed antivenom for hump-nosed viper bites in Sri Lanka. The polyspecific antivenom currently available in Sri Lanka is imported from India – which is manufactured against the Indian species of cobra, Russell’s viper, common krait and saw-scaled viper venom – and does not have antibodies against hump-nosed viper venom. Hence, it is ineffective against hump-nosed viper venom and potentially dangerous due to anaphylactic reactions. Therefore, treatment is restricted to supportive care.
Other investigation results at this point were as follows: serum aspartate aminotransferase (AST) 36 U/L (reference range: 10-35), alanine aminotransferase (ALT) 39 U/L (10-40), alkaline phosphatase 199 U/L (100-360), total bilirubin 38 μmol/L (5-21) (direct fraction 15%), serum ionized calcium 1.2 mmol/L (1-1.3), phosphorus 1.5 mmol/L (0.8-1.5), and magnesium 0.7 mmol/L (0.8-1.1). Blood and urine cultures were sterile. Non-contrast enhanced computed tomography of brain revealed no abnormalities. Magnetic resonance imaging of brain after gadolinium contrast revealed high T2 signal intensities in bilateral periventricular white matter without significant diffusion abnormalities. This was suggestive of white matter ischaemia or cerebral edema.
At the same time it was noted that the serum lactate dehydrogenase levels were significantly elevated (1660 IU/L, reference range 230-460). The overall picture suggested a diagnosis of thrombotic thrombocytopenic purpura (TTP). Despite this complication has never been reported following snakebite, we initiated therapeutic plasma exchange with fresh frozen plasma on day 7. Plasma exchange is the standard treatment for TTP and it was carried out at a frequency of one cycle every 48 hours. Following the third cycle of TPE, there was a gradual improvement in the level of consciousness, but the thrombocytopenia and features of microangiopathic hemolysis (MAHA) in blood film continued. After the seventh cycle of TPE there was a sustained rise in platelet count and features of MAHA gradually disappeared.
In the meantime, fourteen sessions of intermittent hemodialysis were carried out over six weeks, which led to a sustained improvement in renal functions. Her stay in the intensive care unit was also complicated by a ventilator-associated pneumonia and difficulty in weaning from the ventilator. With intense supportive care, intravenous antibiotics and chest physiotherapy, the patient made a full recovery and was discharged from the hospital on day 65. The platelet count picked up to 250,000/μL, lactate dehydrogenase level and other biochemical parameters such as liver and renal function tests were within normal limits at the point of discharge. She was clinically well and gradually returning to her daily routine at home two weeks later in the follow up clinic. She was subsequently discharged from our clinic to be followed up annually at the local hospital with regard to renal functions as cortical necrosis and chronic kidney disease, a potential complication of hump-nosed viper bites.
Adult TTP is an acute syndrome that comprises thrombocytopenia and microangiopathic hemolytic anemia associated with fever, varying degree of neurological dysfunction and renal impairment . TTP exists in a spectrum with its counterpart hemolytic uremic syndrome (HUS). When the neurological impairment is a prominent manifestation, a diagnosis of TTP is favored, and if the renal impairment is prominent, HUS is favored . Our patient had features of both these syndromes but it is not surprising as TTP and HUS are not mutually exclusive. They exist in a spectrum with either entity being at the two extremes. So, there can be patients with a mixed picture.
Most cases of TTP are associated with a deficiency of the metalloproteinase ADAMTS 13, which is responsible for cleavage of unusually large von Willebrand factor multimers in plasma. Its deficiency results in accumulation of these multimers giving rise to platelet aggregation, microthrombi formation and thrombotic microangiopathy . Still, TTP can be observed in patients with normal ADAMTS 13 levels and a proposed hypotheses for pathogenesis in these circumstances include endothelial injury, increased platelet aggregation and increased levels of plasminogen-activator inhibitor type 1 (PAI-1). Acquired causes for adult TTP-HUS spectrum include bloody diarrheas associated with shiga toxin-producing E. coli, drugs (e.g. quinine, mitomycin, tacrolimus, sirolimus, cyclosporine), pregnancy and autoimmune diseases such as systemic lupus erythematosus. While primary or congenital cases of TTP are associated with a reduced level of ADAMTS 13, certain secondary causes of TTP may have normal levels of the enzyme [6, 7].
Venom induced consumptive coagulation (VICC) is a well-known consequence of viper bites . It is also known that some viper venoms, such as those of hump-nosed viper and Russell’s viper, can precipitate renal failure. The common tendency is to view both these manifestations as a part of a same syndrome. VICC is characterized by rapid onset coagulopathy within hours after the snake bite with elevated D-dimer levels, prolonged prothrombin time, and low fibrinogen levels which at times is associated with thrombocytopenia . This resolves within 24 to 48 hours. It is not associated with systemic micro-thrombi and end-organ failure . In two series of hump-nosed viper bites in Sri Lanka, coagulopathy was observed in only 21-39% of the sample [3, 10]. Current evidence suggests that VICC and mechanisms of end organ damage – such as renal failure – are mutually exclusive though they can co-exist. It also follows that one can occur in absence of the other. That will explain the situation with our patient in which end organ failure was observed without any evidence of VICC.
This leads us to the question of the actual pathophysiology of end organ damage (which is renal failure in most occasions) in hump-nosed viper bites. It is thought to be due to venom induced thrombotic microangiopathy (TMA) [4, 11]. It has also been suggested that TMA follows VICC in a subset of patients implicating the same toxin mediated pathology for both conditions . What is interesting with this picture is that TTP-HUS spectrum is also characterized by thrombotic microangiopathy. The more frequent renal failure observed with hump-nosed viper bites is probably not often linked to HUS as there is no coagulopathy in this syndrome (which is frequently observed and mistakenly thought to be linked to renal failure in viper bites). However, if we follow the evidence that VICC is unrelated to organ failure and TMA can happen without VICC by a separate mechanism, then an acquired HUS-like syndrome will explain the clinical picture seen in patients with renal failure after a hump-nosed viper bite . It also follows that if HUS-like manifestations may occur in a victim, TTP-like manifestations may also occur as a part of the same spectrum. Strangely, although renal failure is frequently reported secondary to microangiopathy (HUS equivalent), a TTP-like syndrome has never been reported. One reason may be that it is extremely rare to get a patient at the TTP end of the spectrum compared to the HUS end. Another reason may be that physicians confuse TMA and VICC (which may co-exist by independent mechanisms) to be a part of the same syndrome and misdiagnose the patient as having disseminated intravascular coagulation (DIC) . So any TTP-like symptoms (confusion, seizures) may be attributed to DIC. This can result in inappropriate management strategies that can potentially harm the patient.
Though not exactly fitting to a diagnosis of TTP, syndromes suggestive of TTP-HUS spectrum has been reported in the literature with other venomous animal bites and stings [13–15]. Ho et al. report an interesting case of tiger snake (Notechis scutatus) envenoming in which the patient had a somewhat similar course of illness to our patient. After an initial VICC, the patient had acute renal failure and a high LDH level with normal coagulation parameters. There was also microangiopathic hemolysis that followed resolution of VICC. The ADAMTS 13 levels, however, were normal and the patient did not have other clinical features of TTP. This patient received antivenom and also underwent plasmapheresis with subsequent recovery. However, the authors wondered, since ADAMTS 13 levels were normal, whether plasmapheresis was of any benefit. This observation has also been made by Casamento and Isbister  independently with tiger snake envenoming.
In our opinion, the data is not adequate to either confirm or refute the role of plasmapheresis in similar circumstances. Different envenoming may induce different patterns of clinical syndromes and it may be dangerous to generalize that in all or most snakebites ADAMTS 13 levels are normal. It is simply unknown and further data is necessary for each species. For example, envenoming by the scorpion Hemiscorpius lepturus is known to produce an HUS-like syndrome with low ADAMTS 13 levels and increased anti-ADAMTS 13 antibodies . Furthermore, the clinical syndrome in our patient resembled more a classical picture of TTP than the patients cited in other case reports and there was no specific antivenom available. This justified our decision to go ahead with plasmapheresis based on the clinical picture, which resulted in a positive outcome. Unfortunately measuring ADAMTS 13 levels is a costly technique that is available in reference laboratories and currently not available to us in Sri Lanka. Given the increasing number of patients with acute renal failure and microangiopathy following Hypnale bites, data on ADAMTS 13 levels in Hypnale sp. envenoming should be a focus for further research.
As mentioned above we could not measure the ADAMTS 13 levels in this patient as the assay was unavailable. It is also possible that the renal failure in this patient occurred via an independent mechanism to TMA such as venom induced acute tubular necrosis. It is noted that the TTP-like syndrome (explainable by TMA) resolved rapidly with plasma exchange but the renal impairment took nearly six weeks to improve.
Our patient is an excellent case to support the hypothesis that TMA in hump-nosed viper bites may occur in absence of VICC. Their origins may be related, but are independent. The manifestations of TMA favored a TTP-like syndrome rather than a HUS-like syndrome as she had all five classical features of TTP: fever, thrombocytopenia, microangiopathic hemolysis, renal impairment and neurological dysfunction (in the form of confusion and coma). Her clinical syndrome and relevant laboratory parameters improved after she was treated as for TTP. This unique case of a never before reported manifestation of hump-nosed viper envenoming encourages us to rethink about our current understanding of venom pathophysiology. The literature on this snake is sparse as bites are reported from a restricted geographical area (southern India and Sri Lanka). Our observations fit with the current thinking of venom toxinology and go one step further to show that a hitherto unknown, but theoretically plausible, life-threatening manifestation had actually occurred in real life. This case report also has an important message for clinicians to look out for a TTP-like syndrome in hump-nosed viper bites and not to confuse it with DIC. Appropriate timely treatment can be lifesaving.
Written informed consent was obtained from the patient for publication of this case report.
MW is a registrar in Medicine at the University Medical Unit of National Hospital of Sri Lanka. CR is lecturer in Medicine, Department of Clinical Medicine, Faculty of Medicine, University of Colombo. AG is a professor in Medicine at the Faculty of Medicine, University of Colombo. LG is a consultant hematologist and senior lecturer attached at the Department of Pathology, Faculty of Medicine, University of Colombo.
- Maduwage K, Isbister GK, Silva A, Bowatta S, Mendis S, Gawarammana I: Epidemiology and clinical effects of hump-nosed pit viper (Genus: Hypnale ) envenoming in Sri Lanka. Toxicon 2013, 61: 11–15.View ArticlePubMedGoogle Scholar
- Joseph JK, Simpson ID, Menon NC, Jose MP, Kulkarni KJ, Raghavendra GB, Warrell DA: First authenticated cases of life-threatening envenoming by the hump-nosed pit viper ( Hypnale hypnale ) in India. Trans R Soc Trop Med Hyg 2007, 101(1):85–90. 10.1016/j.trstmh.2006.03.008View ArticlePubMedGoogle Scholar
- Ariaratnam CA, Thuraisingam V, Kularatne SA, Sheriff MH, Theakston RD, de Silva A, Warrell DA: Frequent and potentially fatal envenoming by hump-nosed pit vipers ( Hypnale hypnale and H. nepa ) in Sri Lanka: lack of effective antivenom. Trans R Soc Trop Med Hyg 2008, 102(11):1120–1126. 10.1016/j.trstmh.2008.03.023View ArticlePubMedGoogle Scholar
- Herath N, Wazil A, Kularatne S, Ratnatunga N, Weerakoon K, Badurdeen S, Rajakrishna P, Nanayakkara N, Dharmagunawardane D: Thrombotic microangiopathy and acute kidney injury in hump-nosed viper ( Hypnale species) envenoming: a descriptive study in Sri Lanka. Toxicon 2012, 60(1):61–65. 10.1016/j.toxicon.2012.03.015View ArticlePubMedGoogle Scholar
- Shenkman B, Einav Y: Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. Autoimmun Rev 2014, 13(4–5):584–586.View ArticlePubMedGoogle Scholar
- Lammle B, Kremer Hovinga JA, George JN: Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica 2008, 93(2):172–177. 10.3324/haematol.12701View ArticlePubMedGoogle Scholar
- Sadler JE: Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008, 112(1):11–18. 10.1182/blood-2008-02-078170PubMed CentralView ArticlePubMedGoogle Scholar
- Cheng AC, Wu HL, Shi GY, Tsai IH: A novel heparin-dependent inhibitor of activated protein C that potentiates consumptive coagulopathy in Russell's viper envenomation. J Biol Chem 2012, 287(19):15739–15748. 10.1074/jbc.M111.323063PubMed CentralView ArticlePubMedGoogle Scholar
- Isbister GK: Snakebite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost 2010, 36(4):444–451. 10.1055/s-0030-1254053View ArticlePubMedGoogle Scholar
- Premawardena AP, Seneviratne SL, Gunatilake SB, de Silva HJ: Excessive fibrinolysis: the coagulopathy following Merrem's hump-nosed viper ( Hypnale hypnale ) bites. Am J Trop Med Hyg 1998, 58(6):821–823.PubMedGoogle Scholar
- Maduwage K, Kularatne K, Wazil A, Gawarammana I: Coagulopthy, acute kidney injury and death following Hypnale zara envenoming: the first case report from Sri Lanka. Toxicon 2011, 58(8):641–643. 10.1016/j.toxicon.2011.09.014View ArticlePubMedGoogle Scholar
- Mitrakrishnan JY, Bandula CW, Mitrakrishnan CS, Somaratna K, Jeyalakshmy S: Haemolytic uremic syndrome a hitherto unreported complication of humpnosed viper envenomation. Ind J Hematol Blood Transfus 2013, 29(2):116–118. 10.1007/s12288-012-0156-9View ArticleGoogle Scholar
- Ashley JR, Otero H, Aboulafia DM: Bee envenomation: a rare cause of thrombotic thrombocytopenic purpura. South Med J 2003, 96(6):588–591. 10.1097/01.SMJ.0000051056.23320.09View ArticlePubMedGoogle Scholar
- Valavi E, Ansari MJ, Hoseini S: ADAMTS-13 deficiency following Hemiscorpius lepturus scorpion sting. Saudi J Kidney Dis Transpl 2011, 22(4):792–795.PubMedGoogle Scholar
- Cobcroft RG, Williams A, Cook D, Williams DJ, Masci P: Hemolytic uremic syndrome following taipan envenomation with response to plasmapheresis. Pathology 1997, 29(4):399–402. 10.1080/00313029700169385View ArticlePubMedGoogle Scholar
- Ho WK, Verner E, Dauer R, Duggan J: ADAMTS-13 activity, microangiopathic haemolytic anaemia and thrombocytopenia following snake bite envenomation. Pathology 2010, 42(2):200–202. 10.3109/00313020903493955View ArticlePubMedGoogle Scholar
- Casamento AJ, Isbister GK: Thrombotic microangiopathy in two tiger snake envenomations. Anaesth Intensive Care 2011, 39(6):1124–1127.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.